Therapeutic Drug Monitoring Market

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Therapeutic Drug Monitoring Market contains market size and forecasts of Therapeutic Drug Monitoring in Global, including the following market information:

Global Therapeutic Drug Monitoring Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Therapeutic Drug Monitoring market was valued at 1760.2 million in 2021 and is projected to reach US$ 2618.5 million by 2028, at a CAGR of 5.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Blood Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Therapeutic Drug Monitoring include Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Sanquin and Becton Dickinson and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Therapeutic Drug Monitoring companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Therapeutic Drug Monitoring Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Therapeutic Drug Monitoring Market Segment Percentages, by Type, 2021 (%)

Blood Test

Urine Test

Saliva Test

Other Test

Global Therapeutic Drug Monitoring Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Therapeutic Drug Monitoring Market Segment Percentages, by Application, 2021 (%)

Hospital Labs

Private Labs

Others

Global Therapeutic Drug Monitoring Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Therapeutic Drug Monitoring Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Therapeutic Drug Monitoring revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Therapeutic Drug Monitoring revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Danaher

Abbott

Thermo Fisher Scientific

Siemens Healthcare

Bio-Rad Laboratories

BioMerieux

Sanquin

Becton Dickinson

Quest Diagnostics